Injective (INJ) And Sui (SUI): With Derivatives And High‑Performance DeFi Back In Focus, Do INJ And SUI Lead The Next Speculative Rotation?
As the market enters a new phase of price discovery in April 2026, "High-Performance DeFi" and "On-Chain Derivatives" are once again dominating trader conversations. Injective (INJ) and Sui (SUI) have emerged as the primary candidates to lead this speculative rotation. Both assets are currently showing signs of "early-stage basing"—nudging upward from deeply depressed levels with improving momentum. However, the question remains: are they ready to lead a new bull leg, or are they simply range-bound survivors in a volatile market?
Injective (INJ): Derivatives L1 Trying To Lift Off Its Base
Source: tradingview
Injective (INJ) is purpose-built for the next generation of on-chain derivatives and order-book style trading. Technically, INJ has reclaimed its short-term 7-day ($2.92) and 30-day ($2.98) moving averages, signaling an early recovery. However, the 200-day SMA ($5.59) remains a heavy overhead resistance level. With an RSI-14 at 54.96, momentum is turning up from a negative profile but has not yet matured into a full-scale trend.
INJ Price Scenarios:
-
Base Case: A wide, constructive range between $2.40 and $3.90 (-20% to +30%). In this scenario, the 200-day MA acts as a ceiling while short-term averages provide a floor for accumulation.
-
Bullish Path: A speculative rotation leg targeting $4.10–$4.80 (+35% to +60%). This would require a clear surge in perp DEX volume and higher lows on the daily chart, breaking above recent swing highs with sustained volume.
-
Bearish Path: A failure to hold the current base, leading to a slide toward $2.00–$2.25 (-25% to -35%). This remains a structural risk if derivatives interest rotates elsewhere.
TradingView Tip: Monitor the MACD histogram. Currently at +0.029, it shows early signs of "turning up" from negative territory. A sustained move into positive territory would confirm the transition from a basing phase to a recovery leg.
Sui (SUI): High-Performance L1 With Similar Early Turn
Source: tradingview
Sui (SUI) is often categorized alongside "fast DeFi" and next-gen app chains. Its technical structure mirrors Injective’s: price is sitting just above the 7-day ($0.90) and 30-day ($0.93) moving averages, while the 200-day SMA ($1.65) remains far out of reach. While its monthly performance is slightly softer than INJ's (-4.5%), its short-term technicals are comparable, showing mildly bullish momentum without being overbought.
SUI Price Scenarios:
-
Base Case: A broad L1 range with a mild upside bias, trading between $0.75 and $1.20 (-20% to +30%). SUI is likely to outperform BTC in percentage terms on "green" days but struggle near the $1.65 resistance zone.
-
Bullish Path: A high-performance L1 rotation leg pushing toward $1.25–$1.50 (+35% to +60%). This scenario assumes a market-wide shift back into high-throughput ecosystems with volume expanding on local breakouts.
-
Bearish Path: A continuation of the broader drawdown toward $0.55–$0.70 (-25% to -40%). This would fit the narrative of a prolonged basing process typical of tokens down over 80% from their peaks.
TradingView Tip: Watch the RSI-7 (currently at 62.31). It is positive but not yet extreme. If SUI can maintain this level while price consolidates above the 30-day average, it strengthens the case for a speculative breakout.
Conclusion
INJ and SUI are both up roughly 7-8% on the week, showing early momentum shifts that typically precede a speculative rotation. However, they remain in "early-basing" territory, sitting well below their long-term 200-day moving averages. If on-chain derivatives and high-performance trading volumes continue to accelerate, these two are natural beneficiaries. For now, the data supports a volatile range rather than a guaranteed trend, making them credible candidates to participate in the next rotation, if not yet the established leaders of it.
Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.
Investment Disclaimer
